About the Authors

Caroline Sindet-Pedersen

carolinesindet@gmail.com

Affiliations Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark

Louise Bruun Oestergaard

Affiliations Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark, Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark

Anna Gundlund

Affiliation Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark

Emil Loldrup Fosbøl

Affiliations The Danish Heart Foundation, Copenhagen K, Copenhagen, Denmark, Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen Ø, Denmark

Kristian Aasbjerg

Affiliations Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark, Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark

Jannik Langtved Pallisgaard

Affiliations Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark

Gunnar Gislason

Affiliations Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark, The Danish Heart Foundation, Copenhagen K, Copenhagen, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark, The National Institute of Public Health, University of Southern Denmark, Odense, Denmark

Christian Torp-Pedersen

Affiliations Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark, Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark

Jonas Bjerring Olesen

Affiliation Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark

Competing Interests

J. L. Pallisgaard has received funding for research from Boehringer Ingelheim and Bayer. C. Torp-Pedersen declare research contracts with Bayer and Biotronic and speaker fees for Bayer and BMS. G. H. Gislason has received funding for research from Boehringr Ingelheim, Pfizer, BMS, AstraZeneca and Bayer and declares ownership of stocks in Lundbeck A/S, Novo Nordisk A/S and ALK Abello pharmaceuticals. J. B. Olesen has received speaker fees from Bristol-Myers Squibb, Bayer, and Boehringer Ingelheim, and current funding for research from Bristol-Myers Squibb and The Capital Region of Denmark, Foundation for Health Research. E. L. Fosbøl was previously supported by a project specific research grant from Janssen Pharmaceuticals and has received funding for research from the Lundbeck Foundation and Bristol-Myers Squibb. A. Gundlund has received funding for research from Bristol-Myers Squibb. K. Aasbjerg has nothing to disclose. L. B. Oestergaard has nothing to disclose. C. Sindet-Pedersen has nothing to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: CS LBO AG ELF CTP JBO. Formal analysis: CS LBO AG. Funding acquisition: CS GG. Supervision: JBO LBO AG GG CTP ELF. Writing – original draft: CS. Writing – review & editing: CS LBO AG ELF KA JLP CTP GG JBO.